Skip to content

Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma

Hypotonia as a Clinical Predictor of Optic Pathway Glioma in Children With Neurofibromatosis Type 1

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02584413
Enrollment
29
Registered
2015-10-22
Start date
2013-04-16
Completion date
2019-02-07
Last updated
2019-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurofibromatosis Type 1

Brief summary

Currently, optic pathway gliomas (OPG) are detected based on abnormal findings made during annual ophthalmologic exams. However, because these exams are annual, it is possible for healthcare providers to miss the point at which a child's vision begins to decline (potentially indicating an OPG). If at-risk children are screened for hypotonia early in life, those children who are hypotonic may undergo magnetic resonance imaging (MRI) to evaluate for OPG before they are showing ophthalmologic symptoms. This would enable healthcare providers to discover vision loss earlier and treat symptomatic OPGs earlier, thereby allowing us a better chance of preventing further vision loss in children with OPGs.

Interventions

DEVICEMagnetic resonance imaging

-Standard of care

-Standard of care

Sponsors

St. Louis Children's Hospital
CollaboratorOTHER
Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to 7 Years
Healthy volunteers
No

Inclusion criteria

* Patient must be seen at the St. Louis Children's Hospital NF Clinic * Diagnosis of NF1 * Between 1 and 7 years of age, inclusive * Diagnosed with hypotonia * Legally authorized representative/guardian must be able to understand and willing to sign an IRB-approved informed consent document * Must have an MRI scan ordered by a treating physician

Exclusion criteria

* Normal tone on clinical exam * Known allergy to gadolinium or the sedative, propofol, used during MRI * Poor kidney function defined as a known renal disease or elevated BUN and creatine * Requiring intubation for anesthesia

Design outcomes

Primary

MeasureTime frameDescription
Predictive accuracy of clinical diagnosis of hypotonia as an indicator of OPG in children with NF1At the time of MRI (1 day)* A pediatric nurse practitioner (PNP) or a pediatric physician specializing in NF1, and physical therapist will screen the children for hypotonia. * The MRI scan will show hypotonia if the children have thickening or enlargement of any portion of the optic nerve, optic chiasm, or optic tracts. * The data analysis for this will be descriptive in nature.

Secondary

MeasureTime frameDescription
Other features that may be indicatory of OPG in children with NF1At the time of MRI (1 day)* MRI findings may include other brain tumors or T2 hyperintensities. * The data analysis will be descriptive in nature.
Determine if a physical therapist (PT) can train another clinical professional to accurately diagnose hypotonia1 day-PTs use subjective muscle tone, a pull-to-sit test, and the presence or absence of head lag to determine hypotonia.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026